Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance

  • Kim, Albert E.
  • Lou, Kevin W.
  • Giobbie-Hurder, Anita
  • Chang, Ken
  • Gidwani, Mishka
  • Hoebel, Katharina
  • Patel, Jay B.
  • Cleveland, Mason C.
  • Singh, Praveer
  • Bridge, Christopher P.
  • Rakin Ahmed, Syed
  • Bearce, Benjamin A.
  • Liu, William
  • Lee, Eudocia Q.
  • Fuster García, Elíes|||0000-0002-0716-8960
[EN] Background. We recently conducted a phase 2 trial (NCT028865685) evaluating intracranial efficacy of pembrolizumab for brain metastases (BM) of diverse histologies. Our study met its primary efficacy endpoint and illustrates that pembrolizumab exerts promising activity in a select group of patients with BM. Given the importance of aberrant vasculature in mediating immunosuppression, we explored the relationship between immune checkpoint inhibitor (ICI) efficacy and vascular architecture in the hopes of identifying potential mechanisms of intracranial ICI response or resistance for BM. Methods. Using Vessel Architectural Imaging, a histologically validated quantitative metric for in vivo tumor vascular physiology, we analyzed dual-echo DSC/DCE MRI for 44 patients on trial. Tumor and peri-tumor cerebral blood volume/flow, vessel size, arterial and venous dominance, and vascular permeability were measured before and after treatment with pembrolizumab. Results. BM that progressed on ICI were characterized by a highly aberrant vasculature dominated by largecaliber vessels. In contrast, ICI-responsive BM possessed a more structurally balanced vasculature consisting of both small and large vessels, and there was a trend toward a decrease in under-perfused tissue, suggesting a reversal of the negative effects of hypoxia. In the peri-tumor region, the development of smaller blood vessels, consistent with neo-angiogenesis, was associated with tumor growth before radiographic evidence of contrast enhancement on anatomical MRI. Conclusions. This study, one of the largest functional imaging studies for BM, suggests that vascular architecture is linked with ICI efficacy. Studies identifying modulators of vascular architecture, and effects on immune activity, are warranted and may inform future combination treatments., A.E.K. is supported by an American Brain Tumor Association Basic Research Fellowship In Honor of Paul Fabbri, the William G. Kaelin, Jr., MD, Physician-Scientist Award of the Damon Runyon Cancer Research Foundation, American Association for Cancer Research Breast Cancer Research Fellowship, and American Society of Clinical Oncology Young Investigator Award. E.F.G. was supported by the European Union s Horizon 2020 Programme: Marie Sklodowska-Curie grant agreement No 844646-GLIOHAB and Spanish State Research Agency, Subprogram for Knowledge Generation (PROGRESS, No PID2021-127110OA-I00). P.K.B is supported by the NCI (1R01CA227156-01, 5R21CA220253-02, and 1R01CA244975-01), Damon Runyon Cancer Research Foundation, and Breast Cancer Research Foundation. Y.Y. is supported by the NIH (1R21AG067562-01 and 1R21GM137227-01). K.E.E. is supported by the European Union's Horizon 2020 Programme: ERC Grant Agreement No. 758657-ImPRESS, South-Eastern Norway Regional Health Authority (Grant Agreements No. 2016102, 2017073, 2013069), and the Norwegian Cancer Society and the FRIPRO Grant Agreements No. 261984, 303249). E.R.G. is supported by R01CA211238-01 and R01CA244975.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Non-local spatially varying finite mixture models for image segmentation

  • Juan -Albarracín, Javier
  • Fuster García, Elíes|||0000-0002-0716-8960
  • Juan, Alfons|||0000-0002-9984-4072
  • Garcia-Gomez, Juan M
[EN] In this work, we propose a new Bayesian model for unsupervised image segmentation based on a combination of the spatially varying finite mixture models (SVFMMs) and the non-local means (NLM) framework. The probabilistic NLM weighting function is successfully integrated into a varying Gauss¿Markov random field, yielding a prior density that adaptively imposes a local regularization to simultaneously preserve edges and enforce smooth constraints in homogeneous regions of the image. Two versions of our model are proposed: a pixel-based model and a patch-based model, depending on the design of the probabilistic NLM weighting function. Contrary to previous methods proposed in the literature, our approximation does not introduce new parameters to be estimated into the model, because the NLM weighting function is completely known once the neighborhood of a pixel is fixed. The proposed model can be estimated in closed-form solution via a maximum a posteriori (MAP) estimation in an expectation¿maximization scheme. We have compared our model with previously proposed SVFMMs using two public datasets: the Berkeley Segmentation dataset and the BRATS 2013 dataset. The proposed model performs favorably to previous approaches in the literature, achieving better results in terms of Rand Index and Dice metrics in our experiments., This study is partially supported by Secretaria de Estado de Investigacion, Desarrollo e Innovacion (DPI2016-80054-R, TIN2013-43457-R) and Agencia Valenciana de la Innovacion (INNVAL10/18/048). E.F.G was supported by the European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant agreement (No. 844646) and also acknowledges the support of NVIDIA GPU Grant Program.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Local detection of microvessels in IDH-wildtype glioblastoma using relative cerebral blood volume: an imaging marker useful for astrocytoma grade 4 classification

  • Álvarez-Torres, María del Mar
  • Juan-Albarracín, Javier
  • Reynes, Gaspar
  • Aparici-Robles, Fernando
  • Ferrer Lozano, Jaime
  • Fuster García, Elíes|||0000-0002-0716-8960
  • Garcia-Gomez, Juan M
[EN] Background The microvessels area (MVA), derived from microvascular proliferation, is a biomarker useful for high-grade glioma classification. Nevertheless, its measurement is costly, labor-intense, and invasive. Finding radiologic correlations with MVA could provide a complementary non-invasive approach without an extra cost and labor intensity and from the first stage. This study aims to correlate imaging markers, such as relative cerebral blood volume (rCBV), and local MVA in IDH-wildtype glioblastoma, and to propose this imaging marker as useful for astrocytoma grade 4 classification. Methods Data from 73 tissue blocks belonging to 17 IDH-wildtype glioblastomas and 7 blocks from 2 IDH-mutant astrocytomas were compiled from the Ivy GAP database. MRI processing and rCBV quantification were carried out using ONCOhabitats methodology. Histologic and MRI co-registration was done manually with experts' supervision, achieving an accuracy of 88.8% of overlay. Spearman's correlation was used to analyze the association between rCBV and microvessel area. Mann-Whitney test was used to study differences of rCBV between blocks with presence or absence of microvessels in IDH-wildtype glioblastoma, as well as to find differences with IDH-mutant astrocytoma samples. Results Significant positive correlations were found between rCBV and microvessel area in the IDH-wildtype blocks (p < 0.001), as well as significant differences in rCBV were found between blocks with microvascular proliferation and blocks without it (p < 0.0001). In addition, significant differences in rCBV were found between IDH-wildtype glioblastoma and IDH-mutant astrocytoma samples, being 2-2.5 times higher rCBV values in IDH-wildtype glioblastoma samples. Conclusions The proposed rCBV marker, calculated from diagnostic MRIs, can detect in IDH-wildtype glioblastoma those regions with microvessels from those without it, and it is significantly correlated with local microvessels area. In addition, the proposed rCBV marker can differentiate the IDH mutation status, providing a complementary non-invasive method for high-grade glioma classification., This work was funded by grants from the National Plan for Scientific and Technical Research and Innovation 2017-2020, No. PID2019-104978RB-I00) (JMGG); H2020-SC1-2016-CNECT Project (No. 727560) (JMGG), and H2020SC1-BHC-2018-2020 (No. 825750) (JMGG). M.A.T was supported by DPI201680054-R (Programa Estatal de Promocion del Talento y su Empleabilidad en I + D + i). EFG was supported by the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 844646. The funding body played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Decreased tissue stiffness in glioblastoma by MR elastography is associated with increased cerebral blood flow

  • Svensson, Siri Fløgstad
  • Latysheva, Anna
  • Fraser-Green, Jorunn
  • Nordhoy, Wibeke
  • Darwish, Omar Isam
  • Hovden, Ivar Thokle
  • Holm, Sverre
  • Vik-Mo, Einar O.
  • Sinkus, Ralph
  • Emblem, Kyrre Eeg
  • Fuster García, Elíes|||0000-0002-0716-8960
[EN] Purpose: Understanding how mechanical properties relate to functional changes in glioblastomas may help explain different treatment response between patients. The aim of this study was to map differences in biome-chanical and functional properties between tumor and healthy tissue, to assess any relationship between them and to study their spatial distribution. Methods: Ten patients with glioblastoma and 17 healthy subjects were scanned using MR Elastography, perfusion and diffusion MRI. Stiffness and viscosity measurements G' and G '', cerebral blood flow (CBF), apparent diffusion coefficient (ADC) and fractional anisotropy (FA) were measured in patients' contrast-enhancing tumor, necrosis, edema, and gray and white matter, and in gray and white matter for healthy subjects. A regression analysis was used to predict CBF as a function of ADC, FA, G' and G ''. Results: Median G' and G' ' in contrast-enhancing tumor were 13% and 37% lower than in normal-appearing white matter (P < 0.01), and 8% and 6% lower in necrosis than in contrast-enhancing tumor, respectively (P < 0.05). Tumors showed both inter-patient and intra-patient heterogeneity. Measurements approached values in normalappearing tissue when moving outward from the tumor core, but abnormal tissue properties were still present in regions of normal-appearing tissue. Using both a linear and a random-forest model, prediction of CBF was improved by adding MRE measurements to the model (P < 0.01). Conclusions: The inclusion of MRE measurements in statistical models helped predict perfusion, with stiffer tissue associated with lower perfusion values., Grant Support: We gratefully acknowledge support from the European Union's Horizon 2020 Programme: ERC Grant Agreement No. 758657-ImPRESS, Research and Innovation Grant Agreements No. 668039-FORCE and Marie Sklodowska-Curie grant agreement (No 844646-GLIOHAB), South-Eastern Norway Regional Health Authority (Grant Agreement No. 2017073, 2013069 and 2021057), The Research Council of Norway FRIPRO (Grant Agreement No. 261984), the National Institutes of Health R21 grant (Grant Agreement No. EB030757), and the German Research Foundation (DFG, SCHR 1542/1-1).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Higher vascularity at infiltrated peripheral edema differentiates proneural glioblastoma subtype

  • Chelebian, Eduard
  • Álvarez-Torres, María del Mar
  • Juan-Albarracín, Javier
  • Fuster García, Elíes|||0000-0002-0716-8960
  • Garcia-Gomez, Juan M
[EN] Background and purpose Genetic classifications are crucial for understanding the heterogeneity of glioblastoma. Recently, perfusion MRI techniques have demonstrated associations molecular alterations. In this work, we investigated whether perfusion markers within infiltrated peripheral edema were associated with proneural, mesenchymal, classical and neural subtypes. Materials and methods ONCOhabitats open web services were used to obtain the cerebral blood volume at the infiltrated peripheral edema for MRI studies of 50 glioblastoma patients from The Cancer Imaging Archive: TCGA-GBM. ANOVA and Kruskal-Wallis tests were carried out in order to assess the association between vascular features and the Verhaak subtypes. For assessing specific differences, Mann-Whitney U-test was conducted. Finally, the association of overall survival with molecular and vascular features was assessed using univariate and multivariate Cox models. Results ANOVA and Kruskal-Wallis tests for the maximum cerebral blood volume at the infiltrated peripheral edema between the four subclasses yielded false discovery rate corrected p-values of <0.001 and 0.02, respectively. This vascular feature was significantly higher (p = 0.0043) in proneural patients compared to the rest of the subtypes while conducting Mann-Whitney U-test. The multivariate Cox model pointed to redundant information provided by vascular features at the peripheral edema and proneural subtype when analyzing overall survival. Conclusions Higher relative cerebral blood volume at infiltrated peripheral edema is associated with proneural glioblastoma subtype suggesting underlying vascular behavior related to molecular composition in that area., This work was partially supported by: MTS4up project (National Plan for Scientific and Technical Research and Innovation 2013-2016, No. DPI2016-80054-R) (JMGG); H2020-SC1-2016CNECT Project (No. 727560) (JMGG), Fundacio Bancaria laCaixa (LCF/TR/CI16/10010016) and H2020-SC1-BHC-2018-2020 (No. 825750) (JMGG); PID2019-104978RB-I00 (Ministerio de Ciencia e Innovacion) (JMGG). MAT was supported by DPI2016-80054-R (Programa Estatal de Promocion del Talento y su Empleabilidad en I+D +i). EFG was supported by the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 844646. There was no additional external funding received for this study.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Interpreting deep learning models for glioma survival classification using visualization and textual explanations.

  • Osadebey, Michael
  • Liu, Qinghui
  • Emblem, Kyrre E.
  • Fuster García, Elíes|||0000-0002-0716-8960
[EN] Background Saliency-based algorithms are able to explain the relationship between input image pixels and deeplearning model predictions. However, it may be difcult to assess the clinical value of the most important image features and the model predictions derived from the raw saliency map. This study proposes to enhance the interpret¿ ability of saliency-based deep learning model for survival classifcation of patients with gliomas, by extracting domain knowledge-based information from the raw saliency maps. Materials and methods Our study includes presurgical T1-weighted (pre- and post-contrast), T2-weighted and T2-FLAIR MRIs of 147 glioma patients from the BraTs 2020 challenge dataset aligned to the SRI 24 anatomical atlas. Each image exam includes a segmentation mask and the information of overall survival (OS) from time of diag¿ nosis (in days). This dataset was divided into training (n = 118) and validation (n = 29) datasets. The extent of surgi¿ cal resection for all patients was gross total resection. We categorized the data into 42 short (mean µ = 157 days), 30 medium (µ = 369 days), and 46 long (µ = 761 days) survivors. A 3D convolutional neural network (CNN) trained on brain tumour MRI volumes classifed all patients based on expected prognosis of either short-term, mediumterm, or long-term survival. We extend the popular 2D Gradient-weighted Class Activation Mapping (Grad-CAM), for the generation of saliency map, to 3D and combined it with the anatomical atlas, to extract brain regions, brain volume and probability map that reveal domain knowledge-based information. Results For each OS class, a larger tumor volume was associated with a shorter OS. There were 10, 7 and 27 tumor locations in brain regions that uniquely associate with the short-term, medium-term, and long-term survival, respec¿ tively. Tumors located in the transverse temporal gyrus, fusiform, and palladium are associated with short, medium and long-term survival, respectively. The visual and textual information displayed during OS prediction highlights tumor location and the contribution of diferent brain regions to the prediction of OS. This algorithm design feature assists the physician in analyzing and understanding diferent model prediction stages. Conclusions Domain knowledge-based information extracted from the saliency map can enhance the interpret¿ ability of deep learning models. Our fndings show that tumors overlapping eloquent brain regions are associated with short patient survival., This work was supported by The European Union s Horizon 2020 Programmes ERC Grant Agreement No. 758657-ImPRESS, and Marie Sk&#322;odowska-Curie grant agreement (No 844646-GLIOHAB). The Norwegian Cancer Society and the Research Council of Norway Grants 303249, 261984, 325971. South-Eastern Norway Regional Health Authority Grants 2021057, 2013069, 2017073. Elies Fuster-Garcia was supported by Spanish State Research Agency, Subprogram for Knowledge Generation (PROGRESS, No PID2021-127110OA-I00).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated MGMT

  • Álvarez-Torres, María del Mar
  • Balaña, Carmen
  • Puig, Josep
  • Fuster García, Elíes|||0000-0002-0716-8960
  • Garcia-Gomez, Juan M
[EN] Despite the complete treatment with surgery, chemotherapy and radiotherapy, patients with glioblastoma have a devasting prognosis. Although the role of extending temozolomide treatment has been explored, the results are inconclusive. Recent evidence suggested that tumor vascularity may be a modulating factor in combination with methylation of O6-methylguanine-DNA methyltransferase (MGMT) promotor gene on the effect of temozolomide-based therapies, opening new possibilities for personalized treatments. Before proposing a prospective interventional clinical study, it is necessary to confirm the beneficial effect of the combined effect of MGMT methylation and moderate tumor vascularity, as well as the lack of benefit of temozolomide in patients with a highly vascular tumor.In this study, we evaluated the benefit on survival of the combination of methylation of O6-methylguanine-DNA methyltransferase (MGMT) promotor gene and moderate vascularity in glioblastoma using a retrospective dataset of 123 patients from a multicenter cohort. MRI processing and calculation of relative cerebral blood volume (rCBV), used to define moderate- and high-vascular groups, were performed with the automatic ONCOhabitats method. We assessed the previously proposed rCBV threshold (10.7) and the new calculated ones (9.1 and 9.8) to analyze the association with survival for different populations according to vascularity and MGMT methylation status. We found that patients included in the moderate-vascular group had longer survival when MGMT is methylated (significant median survival difference of 174 days, p = 0.0129*). However, we did not find significant differences depending on the MGMT methylation status for the high-vascular group (p = 0.9119). In addition, we investigated the combined correlation of MGMT methylation status and rCBV with the prognostic effect of the number of temozolomide cycles, and only significant results were found for the moderate-vascular group. In conclusion, there is a lack of benefit of extending temozolomide treatment for patients with high vascular glioblastomas, even presenting MGMT methylation. Preliminary results suggest that patients with moderate vascularity and methylated MGMT glioblastomas would benefit more from prolonged adjuvant chemotherapy., M.A-T was supported by DPI2016-80054-R (Programa Estatal de Promocion del Talento y su Empleabilidad en I+D+i). This work was partially supported by the ALBATROSS project (National Plan for Scientific and Technical Research and Innovation 2017-2020, No. PID2019-104978RB-I00). This study was partially funded by the Fundacio La Marato TV3 (665/C/2013) (http://www.ccma.cat/tv3/marato/projectes-financats/2012/231/ Accessed on 8th September 2021). (JMGG); H2020-SC1-2016-CNECT Project (No. 727560) (JMGG), and H2020-SC1-BHC-2018-2020 (No. 825750) (JMGG). EFG was supported by the European Unions Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 844646 and South-Eastern Norway Regional Health Authority Grant 2021057.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Differential effect of vascularity between long- and short-term survivors with IDH1/2 wild-type glioblastoma

  • Álvarez-Torres, María del Mar
  • Reynes, Gaspar
  • Juan-Albarracín, Javier
  • Chelebian-Kocharyan, Eduard Artur
  • Oleaga, Laura
  • Pineda, Jose
  • Auger, Cristina
  • Rovira, Alex
  • Emblem, Kyrre E.
  • Filice, Silvano
  • Molla-Olmos, Enrique
  • Garcia-Gomez, Juan M
  • Fuster García, Elíes|||0000-0002-0716-8960
[EN] Introduction: IDH1/2 wt glioblastoma (GB) represents the most lethal tumour of the central nervous system. Tumour vascularity is associated with overall survival (OS), and the clinical relevance of vascular markers, such as rCBV, has already been validated. Nevertheless, molecular and clinical factors may have different influences on the beneficial effect of a favourable vascular signature. Purpose: To evaluate the association between the rCBV and OS of IDH1/2 wt GB patients for long-term survivors (LTSs) and short-term survivors (STSs). Given that initial high rCBV may affect the patient's OS in follow-up stages, we will assess whether a moderate vascularity is beneficial for OS in both groups of patients. Materials and methods: Ninety-nine IDH1/2 wt GB patients were divided into LTSs (OS >= 400 days) and STSs (OS < 400 days). Mann-Whitney and Fisher, uni- and multiparametric Cox, Aalen's additive regression and Kaplan-Meier tests were carried out. Tumour vascularity was represented by the mean rCBV of the high angiogenic tumour (HAT) habitat computed through the haemodynamic tissue signature methodology (available on the ONCOhabitats platform). Results: For LTSs, we found a significant association between a moderate value of rCBV(mean) and higher OS (uni- and multiparametric Cox and Aalen's regression) (p = 0.0140, HR = 1.19; p = 0.0085, HR = 1.22) and significant stratification capability (p = 0.0343). For the STS group, no association between rCBV(mean) and survival was observed. Moreover, no significant differences (p > 0.05) in gender, age, resection status, chemoradiation, or MGMT methylation were observed between LTSs and STSs. Conclusion: We have found different prognostic and stratification effects of the vascular marker for the LTS and STS groups. We propose the use of rCBV(mean) at HAT as a vascular marker clinically relevant for LTSs with IDH1/2 wt GB and maybe as a potential target for randomized clinical trials focused on this group of patients., DPI2016-80054-R (Programa Estatal de Promocion del Talento y su Empleabilidad en I +D+i).; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 844646; H2020-SC1-BHC-2018-2020 (No. 825750); MTS4up project (National Plan for Scientific and Technical Research and Innovation 2013-2016, No. DPI2016-80054-R); European Union's Horizon 2020 research and innovation programme under Marie Sklodowska-Curie, Grant/Award Number: 844646; Research Council of Norway, Grant/Award Number: 261984; South-Eastern Norway Regional Health Authority, Grant/Award Number: 2017073; European Research Council (ERC) under the European Union's Horizon 2020, Grant/Award Number: 758657
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Robust association between vascular habitats and patient prognosis in glioblastoma: an international retrospective multicenter study

  • Álvarez-Torres, María del Mar
  • Juan-Albarracín, Javier
  • Bellvís-Bataller, Fuensanta
  • Lorente, David
  • Reynés, Gaspar
  • Font de Mora, Jaime
  • Aparici-Robles, Fernando
  • Botella, Carlos
  • Muñoz-Langa, Jose
  • Faubel, Raquel
  • García-Ferrando, Germán A.
  • Chelebian, Eduard
  • Auger, Cristina
  • Pineda, Jose
  • Rovira, Alex
  • Oleaga, Laura
  • Mollà Olmos, Enrique
  • Revert, Antonio J.
  • Tshibanda, Luaba
  • Crisi, Girolamo
  • Emblem, Kyrre E.
  • Martin, Didier
  • Due-Tønnessen, Paulina
  • Meling, Torstein R.
  • Filice, Silvano
  • Fuster García, Elíes|||0000-0002-0716-8960
  • Asensio-Cuesta, Sabina|||0000-0003-0246-3773
  • Sáez Silvestre, Carlos|||0000-0003-2678-8249
  • Garcia-Gomez, Juan M
[EN] Background Glioblastoma (GBM) is the most aggressive primary brain tumor, characterized by a heterogeneous and abnormal vascularity. Subtypes of vascular habitats within the tumor and edema can be distinguished: high angiogenic tumor (HAT), low angiogenic tumor (LAT), infiltrated peripheral edema (IPE), and vasogenic peripheral edema (VPE). Purpose To validate the association between hemodynamic markers from vascular habitats and overall survival (OS) in glioblastoma patients, considering the intercenter variability of acquisition protocols. Study Type Multicenter retrospective study. Population In all, 184 glioblastoma patients from seven European centers participating in the NCT03439332 clinical study. Field Strength/Sequence 1.5T (for 54 patients) or 3.0T (for 130 patients). Pregadolinium and postgadolinium-based contrast agent-enhanced T-1-weighted MRI, T-2- and FLAIR T-2-weighted, and dynamic susceptibility contrast (DSC) T-2* perfusion. Assessment We analyzed preoperative MRIs to establish the association between the maximum relative cerebral blood volume (rCBV(max)) at each habitat with OS. Moreover, the stratification capabilities of the markers to divide patients into "vascular" groups were tested. The variability in the markers between individual centers was also assessed. Statistical Tests Uniparametric Cox regression; Kaplan-Meier test; Mann-Whitney test. Results The rCBV(max) derived from the HAT, LAT, and IPE habitats were significantly associated with patient OS (P < 0.05; hazard ratio [HR]: 1.05, 1.11, 1.28, respectively). Moreover, these markers can stratify patients into "moderate-" and "high-vascular" groups (P < 0.05). The Mann-Whitney test did not find significant differences among most of the centers in markers (HAT: P = 0.02-0.685; LAT: P = 0.010-0.769; IPE: P = 0.093-0.939; VPE: P = 0.016-1.000). Data Conclusion The rCBV(max) calculated in HAT, LAT, and IPE habitats have been validated as clinically relevant prognostic biomarkers for glioblastoma patients in the pretreatment stage. This study demonstrates the robustness of the hemodynamic tissue signature (HTS) habitats to assess the GBM vascular heterogeneity and their association with patient prognosis independently of intercenter variability. Technical Efficacy Stage: 2 J. Magn. Reson. Imaging 2019., This work was partially supported by: MTS4up project (National Plan for Scientific and Technical Research and Innovation 2013-2016, No. DPI2016-80054-R) (to J.M.G.G.); H2020-SC1-2016-CNECT Project (No. 727560) (to J.M.G.G.) and H2020-SC1-BHC-2018-2020 (No. 825750) (to J.M.G.G.); M.A.T was supported by DPI2016-80054-R (Programa Estatal de Promocion del Talento y su Empleabilidad en I + D + i). The data acquisition and curation of the Oslo University Hospital was supported by: the European Research Council (ERC) under the European Union's Horizon 2020 (Grant Agreement No. 758657), the South-Eastern Norway Regional Health Authority Grants 2017073 and 2013069, and the Research Council of Norway Grants 261984 (to K.E.E.). We gratefully acknowledge the support of NVIDIA Corporation with the donation of the Titan V GPU used for this research. E.F.G. was supported by the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 844646. Figure 1 was designed by the Science Artist Elena Poritskaya.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

MGMT methylation may benefit overall survival in patients with moderately vascularized glioblastomas

  • Fuster García, Elíes|||0000-0002-0716-8960
  • Garcia-Gomez, Juan M
  • Lorente Estellés, David
  • Álvarez-Torres, María del Mar
  • Juan-Albarracín, Javier
  • Chelebian-Kocharyan, Eduard Artur
  • Rovira, Alex
  • Auger Acosta, Cristina
  • Pineda, Jose
  • Oleaga, Laura
  • Mollá-Olmos, Enrique
  • Filice, Silvano
  • Due-Tonnessen, Paulina
  • Meling, Torstein R.
  • Emblem, Kyrre E.
[EN] Objectives To assess the combined role of tumor vascularity, estimated from perfusion MRI, andMGMTmethylation status on overall survival (OS) in patients with glioblastoma. Methods A multicentric international dataset including 96 patients from NCT03439332 clinical study were used to study the prognostic relationships betweenMGMTand perfusion markers. Relative cerebral blood volume (rCBV) in the most vascularized tumor regions was automatically obtained from preoperative MRIs using ONCOhabitats online analysis service. Cox survival regression models and stratification strategies were conducted to define a subpopulation that is particularly favored byMGMTmethylation in terms of OS. Results rCBV distributions did not differ significantly (p > 0.05) in the methylated and the non-methylated subpopulations. In patients with moderately vascularized tumors (rCBV < 10.73),MGMTmethylation was a positive predictive factor for OS (HR = 2.73,p = 0.003, AUC = 0.70). In patients with highly vascularized tumors (rCBV > 10.73), however, there was no significant effect ofMGMTmethylation (HR = 1.72,p = 0.10, AUC = 0.56). Conclusions Our results indicate the existence of complementary prognostic information provided byMGMTmethylation and rCBV. Perfusion markers could identify a subpopulation of patients who will benefit the most fromMGMTmethylation. Not considering this information may lead to bias in the interpretation of clinical studies., Open Access funding provided by University of Oslo (incl Oslo University Hospital). This study has received funding from MTS4up project (National Plan for Scientific and Technical Research and Innovation 2013-2016, No. DPI2016-80054-R) (JMGG); H2020-SC12016-CNECT Project (No. 727560) (JMGG), H2020-SC1-BHC-20182020 (No. 825750) (JMGG), the European Research Council (ERC) under the European Union's Horizon 2020 (Grant Agreement No. 758657), the South-Eastern Norway Regional Health Authority Grants 2017073 and 2013069, the Research Council of Norway Grants 261984 (KEE). M.A.T was supported by Programa Estatal de Promocion del Talento y su Empleabilidad en I+D+i (DPI2016-80054-R). E.F.G was supported by the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement (No. 844646).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Quantification of Tissue Compression Identifies High-Grade Glioma Patients with Reduced Survival

  • Fuster García, Elíes|||0000-0002-0716-8960
  • Hovden, Ivar Thokle
  • Fløgstad Svensson, Siri
  • Larsson, Christopher
  • Vardal, Jonas
  • Bjørnerud, Atle
  • Emblem, Kyrre E.
[EN] The compression of peritumoral healthy tissue in brain tumor patients is considered a major cause of the life-threatening neurologic symptoms. Although significant deformations caused by the tumor growth can be observed radiologically, the quantification of minor tissue deformations have not been widely investigated. In this study, we propose a method to quantify subtle peritumoral deformations. A total of 127 MRI longitudinal studies from 23 patients with high-grade glioma were included. We estimate longitudinal displacement fields based on a symmetric normalization algorithm and we propose four biomarkers. We assess the interpatient and intrapatient association between proposed biomarkers and the survival based on Cox analyses, and the potential of the biomarkers to stratify patients according to their survival based on Kaplan¿Meier analysis. Biomarkers show a significant intrapatient association with survival (p < 0.05); however, only compression biomarkers show the ability to stratify patients between those with higher and lower overall survival (AUC = 0.83, HR = 6.30, p < 0.05 for CompCH). The compression biomarkers present three times higher Hazard Ratios than those representing only displacement. Our study provides a robust and automated method for quantifying and delineating compression in the peritumoral area. Based on the proposed methodology, we found an association between lower compression in the peritumoral area and good prognosis in high-grade glial tumors., This work was partially supported by: The European Research Council (ERC) under the European Union's Horizon 2020 (Grant Agreement No 758657), the South-Eastern Norway Regional Health Authority Grants 2017073 and 2013069, the Research Council of Norway Grants 261984 and 325971 (K.E.E.), The European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie (Grant Agreement No 844646), and South-Eastern Norway Regional Health Authority Grant 2021057 (E.F.G.).